Israel Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Positive Clinical Results With FMXIN002 Intranasal Powder Epinephrine Spray
TEL AVIV, Israel, Aug. 8, 2023. Nasus Pharma Ltd a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based Intranasal (PBI) product portfolio, to address acute medical conditions announced the publication of positive... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 8, 2023 Category: Pharmaceuticals Source Type: clinical trials

Personalized Need-focused Single Session Intervention
Condition: Depression and/or Anxiety in the Mild-to-moderate Range Intervention: Behavioral: Clinician-administered Need-focused Single Session Intervention Sponsors: Bar-Ilan University, Israel; University of California, Berkeley; United States - Israel Binational Science Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials